Unlocking the Secrets of Technology Transfer in Cell and Gene Therapy: Roberto Formisano’s Expert Interview at Terrapin’s Advanced Therapies Conference

Current developments in technology transfer to a Contract Development and Manufacturing Organization (CDMO)

Roberto Formisano, Process Transfer Senior Manager at AGC Biologics, shares his expertise on the challenges of technology transfer during a video interview. He provides insights into the nuances of technology transfer from development to GMP manufacturing and from customer to contract development and manufacturing organization (CDMO).

One of the significant challenges that Roberto discusses is the critical timelines that are essential for the technology transfer process. Balancing the number of batches required to produce sufficient quality data while adhering to these timelines can be challenging in the industry.

Furthermore, Roberto predicts technology and manufacturing trends that will shape the cell and gene therapy industry by 2024. His insights offer valuable perspectives on the future direction of the industry, providing valuable insights into its complexities and opportunities.

Roberto Formisano had a conversation with EPR editor Caroline Peachey at Terrapin’s Advanced Therapies conference in London on 19 March. The interview sheds light on the complexities of technology transfer and offers valuable insights into the industry’s challenges and opportunities.

Roberto Formisano, Process Transfer Senior Manager at AGC Biologics, shares his expertise on the challenges of technology transfer during a video interview. He provides insights into the nuances of technology transfer from development to GMP manufacturing and from customer to contract development and manufacturing organization (CDMO). One of the significant challenges that Roberto discusses is…

Leave a Reply